Clinical Trial

Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate and compare the safety and pharmacokinetic profiles of "AJU-G721" (test drug) and "G721R" (reference drug) in healthy adult male subjects.
Trial Details
NCT Number NCT07643233
Lead Sponsor AJU Pharm Co., Ltd.
Conditions Moderate-to-severe Benign Prostatic Hyperplasia (BPH)
Enrollment 36 participants
Start Date 2026-07
Primary Completion 2026-07 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-11